Page last updated: 2024-10-16

5-hydroxytryptophan and Acquired Metabolic Diseases, Brain

5-hydroxytryptophan has been researched along with Acquired Metabolic Diseases, Brain in 1 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
" Here, we present a case of PTPS deficiency which showed a more significant correlation of dosage of L-Dopa/carbidopa with serum prolactin levels than with CSF HVA levels."1.35A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels. ( Kanazawa, M; Kitani, Y; Kohno, Y; Ogawa, A; Shintaku, H; Takayanagi, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogawa, A1
Kanazawa, M1
Takayanagi, M1
Kitani, Y1
Shintaku, H1
Kohno, Y1

Other Studies

1 other study available for 5-hydroxytryptophan and Acquired Metabolic Diseases, Brain

ArticleYear
A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
    Brain & development, 2008, Volume: 30, Issue:1

    Topics: 5-Hydroxytryptophan; Biomarkers; Biopterins; Brain Diseases, Metabolic; Child, Preschool; Dopamine;

2008